|
Department of Health and Human Services |
|
Research, Demonstration, and Evaluation Activities
FY 2003 Plan and Budget
February 2002 |
RESEARCH AND DEMONSTRATIONS
(by HHS Strategic Plan Objective)
REDUCE THE INCIDENCE AND IMPACT OF INFECTIOUS DISEASES (OBJECTIVE 1.7)
Table VII
(Dollars in thousands) |
PROGRAM |
FY 2001 Actual |
FY 2002 Appropriation |
FY 2003 Presidents Budget Request |
NATIONAL IMMUNIZATION PROGRAM (CDC) |
$46,717 |
$50,169 |
$50,169 |
Infectious Disease - Sexually Transmitted Diseases (CDC) |
$57,304 |
$57,154 |
$57,154 |
Total |
$104,021 |
$107,323 |
$107,323 |
FY 2003 Priorities
NATIONAL IMMUNIZATION PROGRAM (CDC)
Research: CDC will support research to reduce disease, disability, and
death from vaccine- preventable illnesses. FY2003 Priorities include:
- improving existing vaccines and developing new and/or combined
vaccines.
- developing methods for tracking immunization levels (such as
community/state population-based immunization registries), parent
reminder/recall, mandatory immunization laws, and assessing provider and
community efficiency in delivering vaccines.
- research to determine the occurrence of infrequent adverse events
following vaccination and to investigate the validity of claims that vaccines
are causing specific conditions.
Demonstrations: Priorities include:
- determining the best means of most effectively communicating
immunization schedule changes.
- developing strategies to improve the delivery of vaccines to high risk
groups.
Evaluations: CDC will support evaluation activities to prevent disease,
disability, or death from vaccine-preventable diseases in children and adults.
FY2003 priorities include:
- the National Immunization Survey (NIS) which provides estimates of
immunization coverage levels of two-year-old children in the U.S. and measures
progress toward achieving immunization objectives.
- the nationwide Vaccine Adverse Events Reporting System (VAERS).
INFECTIOUS DISEASE - SEXUALLY TRANSMITTED DISEASE (CDC)
Research: CDC will support research to:
- develop methods to estimate new HIV infections (incidence) and monitor
HIV incidence and prevalence in the United States.
- develop methods to identify HIV-infected persons and link them to care
and effective prevention services.
- develop and test effective and sustainable behavioral, social, and
structural interventions to prevent HIV/AIDS.
- synthesize HIV prevention literature to systematically identify
effective behavioral, social, and policy interventions; factors associated with
their effectiveness; and needs for new intervention.
- identify the behavioral, social, structural, and biomedical
determinants among various populations.
- reduce the incidence and impact of infectious diseases through
epidemiological studies.
Demonstrations: Priorities for FY 2003 include: identify effective
models for increasing knowledge of serostatus among HIV-positive persons who
are unaware of their status; identify effective models for increasing HIV
prevention interventions for HIV-positive persons; identify effective models
for strengthening the HIV prevention-treatment interface; identify effective
models for transferring effective, research-based interventions to HIV
prevention providers for implementation in field settings; and identify
continuity of care models for HIV inmates in corrections settings, addressing
their treatment and care needs on the inside, and linking them to treatment and
care upon release with case management followup (in collaboration with HRSA).
Evaluations: CDC will support evaluation activities to:
- Assess prevention programs funded by health departments that are
intended to influence HIV-positive persons to reduce their risk of infecting
others and to determine the elements of effective HIV prevention for HIV
positives.
- Assess outcomes and cost-effectiveness of community based
interventions for high risk populations to better understand what works and
what does not work for strengthening prevention effectiveness for the future.
- Assess the referrals and linkages to medical and social service
organizations utilized by Community Based Organizations (CBO) to determine
their effectiveness for primary and secondary prevention.
- Assess innovative approaches to HIV counseling and testing using rapid
tests to increase testing rates in racial and ethnic minorities in community
settings such as STD clinics and street outreach.